Share the post "Shareholding Pattern: Shareholding Pattern Jenburkt Pharmaceuticals Ltd. An Examination of Financial Performance for FY (Q4-Mar 2023-2024)"
Jenburkt Pharmaceuticals Ltd. has unveiled its latest shareholding reports, covering the quarter and the first half of the fiscal year ending on (Q4-Mar 2023-2024).This comprehensive report offers a deep dive into the company’s shareholding landscape, including details on Promoters, promoter groups, Foreign investors, public investors, and government entities. Through meticulous comparative analysis, it tracks the evolution of shareholding percentages and quantities, highlighting any shifts in ownership dynamics. Investors gain invaluable insights into the company’s ownership structure and the evolving investment landscape.
Shareholder Name | Previous Quater Quantity(In Crores) | Current Quater Quantity(In Crores) | Previous Quater Shares(in %) | Current Quater Shares(in %) | Quater to Quater Difference |
---|---|---|---|---|---|
Promoters | 0.21 | 0.21 | 47.39 | 47.23 | -0.16 % |
Public | 0.23 | 0.23 | 52.61 | 52.77 | +0.16 % |
DII | 0 | 0 | 0 | 0 | 0 |
FII | 0 | 0 | 0 | 0 | 0 |
Government | 0.00 | 0.00 | 0 | 0 | 0 |
Promoters’ shareholding decreased from 47.39% in December 2023 to 47.23% in March 2024. This reduction indicates that the promoters’ control over Company has weakened during this period.During quater from December 2023 to March 2024, Goverenment ownership remained steady at 0%.This indicates that the government’s stake in the company remained consistent during this period.
Let’s delve deeper into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
Shareholder Name | Previous Quarter Quantity (In crores) | Current Quarter Quantity (In crores) | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
---|---|---|---|---|---|
PRAKASH H BHUTA | 0.003 | 0.002 | 0.67 | 0.52 | -0.15 % |
JAGRUTI KETAN BHUTA | 0.003 | 0.003 | 0.65 | 0.63 | -0.02 % |
PRAKASH H BHUTA faced a downturn in profitability this quarter, witnessing a decline of -0.15 % in profits compared to the previous quarter. Delving into the underlying factors driving this shift is crucial for charting a path towards sustained financial growth.JAGRUTI KETAN BHUTA faced a downturn in profitability this quarter, witnessing a decline of -0.02 % in profits compared to the previous quarter. Delving into the underlying factors driving this shift is crucial for charting a path towards sustained financial growth.
Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
---|---|---|---|---|---|
Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 0.136 | 0.139 | 30.86 | 31.52 | + 0.66 % |
Non Resident Indians (NRIs) | 0.015 | 0.015 | 3.48 | 3.5 | + 0.02 % |
Bodies Corporate | 0.016 | 0.014 | 3.59 | 3.08 | -0.51 % |
OPTIRATIONAL VENTURES LLP | 0.005 | 0.005 | 1.2 | 1.14 | -0.06 % |
Any Other (specify) | 0.006 | 0.006 | 1.43 | 1.41 | -0.02 % |
HUF | 0.006 | 0.005 | 1.26 | 1.23 | -0.03 % |
Clearing Members | 0.000 | 0.000 | 0.08 | 0.09 | + 0.01 % |
Spearheading a savvy charge towards increased profitability, Resident Individuals holding nominal share capital up to Rs. 2 lakhs lifts the bar with a remarkable 0.66 % enhancement in net profit, revealing adroit resource allocation and sharpened commercial instincts.Spearheading a savvy charge towards increased profitability, Non Resident Indians (NRIs) lifts the bar with a remarkable 0.02 % enhancement in net profit, revealing adroit resource allocation and sharpened commercial instincts.Observations indicate a sizeable -0.51 % variance in Bodies Corporate’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.06 % variance in OPTIRATIONAL VENTURES LLP’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.02 % variance in Any Other (specify)’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.03 % variance in HUF’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Spearheading a savvy charge towards increased profitability, Clearing Members lifts the bar with a remarkable 0.01 % enhancement in net profit, revealing adroit resource allocation and sharpened commercial instincts.
[my_shortcode1 values=”Jenburkt Pharmaceuticals Ltd. “]